Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dopamine D2/3 Receptor Availability”

3 trials

Showing 3 of 3 results

Post-approval studies (Phase 4)Looking for participantsNCT06763172
What this trial is testing

Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI

Who this might be right for
HealthyCaffeineAdenosine+1 more
Hsiao-Ying Wey 12
Not applicableActive Not RecruitingNCT03911726
What this trial is testing

Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Central Institute of Mental Health, Mannheim 140
Early research (Phase 1)Ended earlyNCT03059563
What this trial is testing

Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users

Who this might be right for
Dopamine D2/3 Receptor AvailabilityCognitive FunctionMethamphetamine Abuse
University of California, Los Angeles 62

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation